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ABSTRACT 
Objective: To determine the association of socio-demographic and clinic-pathological risk factors with oral 
cancer in Kelantan, Malaysia. Material and Methods: A 19-year cross-sectional survey was performed in 
Hospital Universiti Sains Malaysia (HUSM), Malaysia. Medical record of 301 oral cancer patients was 
retrieved from the Medical Records office. Results: The majority of the oral cancer cases were male (62.8%), 
non-smokers (57.5%), non-alcohol consumers (83.4%), non-betel quid chewers (96.7%), and belonged to 
Malay ethnicity (68.8%). At the time of diagnosis, most of the patients were at stage II (38.9%). 
Approximately one-third (30.6%) of the total OC patients experienced loco-regional/distant metastasis, 
whereas no metastasis was detected in around two-thirds of cases (69.4%). A combination of surgery and 
radiotherapy was the most commonly employed treatment modality (27.2%). At the time of this study, the 
survival status of most of the patients was alive (69.1%). The most frequently encountered oral cancer in the 
Kelantanese population was oral squamous cell carcinoma (70.1%), with the tongue being the most 
frequently involved oral cavity site (35.5%). Conclusion: More than three-fourths of the cases were alive at 
follow-up, which included the cases that did not undergo any form of treatment. 
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Introduction 
Globally, cancer is a disease of great concern due to its incidence and mortality [1]. According to the 
World Health Organization (WHO), by 2030, approximately 75 million individuals will be having cancer [2]. 
Oral cancer (OC) is one of the ten most commonly occurring cancers worldwide and it is attributed as the 
leading cause of death in certain geographical regions such as South-Central Asia [3]. It was estimated that in 
2018, 407,600 people were affected by OC globally; approximately half of whom (199,560) died of the disease. 
Unfortunately, around two-thirds of these cases were reported in developing countries [4].  
There is a wide disparity in the prevalence of OC by geographical area and sex [5]. Variations have 
been recognized at the molecular level and the clinic-pathological behavior in alcohol-associated and tobacco-
smoking OC in Japan, United States (US), France, United Kingdom, as well as tobacco-chewing oral 
carcinomas in Southeast Asia [6]. In Malaysia, the Indian race was detected to have a higher risk of OC than 
Malays and Chinese [7]. 
Studies report that men over 50 years of age are at an increased risk of developing OC [1,8]. 85% of 
OC in women and 93% of OC in men are determined by lifestyle factors such as tobacco smoking, betel quid 
chewing, alcohol intake, the presence of pre-malignant lesions, etc. [9]. 
Oral squamous cell carcinoma (OSCC) is the most commonly encountered histological type (90%) of 
OC [8]. Posterior-lateral border and ventral surfaces of the tongue are the most frequently involved sites in 
tongue cancers, followed by the mouth floor. Relatively less common intra-oral sites are gingiva, hard palate, 
buccal and labial mucosa [10]. The site of the primary tumor occurrence, the tumor size (T stage), nodal 
metastasis (N stage) and extra-capsular spread of the primary tumor dictates the treatment modality – 
chemotherapy (CT), radiotherapy (RT), surgery, or a combination [11]. The OC's successful treatment 
outcome depends on the appropriate management of both the loco-regional lymphatics and the primary site 
[11]. 
This study aimed to determine the association of socio-demographic and clinic-pathological risk 
factors with oral cancers in Kelantan, Malaysia. 
 
Material and Methods 
Study Design and Sample 
This was a retrospective cross-sectional study that comprised a collection of 301 OC patients’ socio-
demographic data, clinicopathological feature data, type and treatment modalities. The study site was Hospital 
Universiti Sains Malaysia (HUSM), Kelantan, which is located in northeastern Peninsular Malaysia. The 
required data were obtained from the medical record office of HUSM between January 2000 and December 
2018. 
 
Data Collection  
The registration numbers of patients were retrieved from a computerized database search for all OC 
patients in the Records Unit of HUSM, and the histopathology reports were cross-examined from the archives 
of Oral Pathology Laboratory of HUSM. Few records of patients diagnosed with OC were retrieved from Oral 
Pathology Laboratory archives at the School of Dental Sciences, USM. A standardized data collection 
proforma was used to collect the relevant data of the patients. Records with missing information were 
excluded. 
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Data Analysis 
Statistical Package for the Social Sciences (SPSS version 24.0 IBM, Armonk, NY: IBM Corp, USA) 
was used for data analysis. To calculate the absolute and relative frequencies, descriptive statistics were used.  
 
Ethical Aspects 
Human Ethics and Committee Universiti Sains Malaysia (USM) granted ethical approval. This 
research was performed in conformity with the Jawatankuasa Etika Penyeldikan (Manusia), USM, Malaysia 
(JEPeM code – USM/JEPeM/18100613). 
 
Results 
A total of 368 OC cases were registered. Of these, 301 cases were included. Sixty-seven OC cases were 
excluded due to missing and/or lost data in medical records. The final analysis was done on the data of 301 
patients. 
 
Socio-Demographic Features 
The mean age was 55 years. Most of the participants were male (62.8%), non-smoker (57.5%), non-
alcohol consumer (83.4%) and non-betel quid chewer (96.7%) and Malay (68.8%) (Table 1). 
 
Table 1. Socio-demographic features of oral cancer patients. 
Variables N (%) 
Age (in Years)  55.0 (Mean) 
Gender  
Male 189 (62.8) 
Female 112 (37.2) 
Ethnicity  
Malay 207 (68.8) 
Indian 63 (20.9) 
Chinese 31 (10.3) 
Tobacco Consumption  
Smoker 128 (42.5) 
Non-Smoker 173 (57.5) 
Alcohol Intake  
User 50 (16.6) 
Non-User 251 (83.4) 
Betel Quid Use  
User 10 (3.3) 
Non-User 291 (96.7) 
Past Family History of Tumor  
Yes 69 (22.9) 
No 232 (77.1) 
HPV Predisposing Factors  
Yes 63 (20.9) 
No 238 (79.1) 
 
The majority of the cases were diagnosed as stage II at the time of diagnosis (38.9%). A total of 30.6% 
of patients experienced loco-regional/distant metastasis, whereas no metastasis was detected in 69.4%. The 
majority of the patients received a combination of surgery and RT as the mode of treatment (27.2%). When 
this study was performed, the survival status of the majority of the patients was alive (69.1%) (Table 2). 
Oral squamous cell carcinoma was the most frequently encountered OC in the Kelantanese population 
(70.1%), followed by mucoepidermoid carcinoma (8.3%) and adenoid cystic carcinoma (5.6%) (Table 3). 
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Table 2. Clinicopathological features of oral cancer patients. 
Variables N (%) 
T Classification  
T1 37 (12.3) 
T2 117 (38.9) 
T3 48 (15.9) 
T4a, T4b, T4c 99 (32.9) 
N Classification  
N0 42 (13.9) 
N1 75 (24.9) 
N2a, N2b, N2c 138 (45.8) 
N3 46 (15.4) 
M Classification  
M0 209 (69.4) 
M1 92 (30.6) 
TNM Staging  
Stage I 27 (9.0) 
Stage II 38 (12.6) 
Stage III 96 (31.9) 
Stage IVa, IVb, IVc 140 (46.5) 
Treatment  
Surgery 43 (14.3) 
Surgery + Chemotherapy 20 (6.6) 
Surgery + Radiotherapy 82 (27.2) 
Surgery + Chemotherapy + Radiotherapy 28 (9.3) 
Radiotherapy 50 (16.6) 
Radiotherapy + Chemotherapy 22 (7.3) 
Chemotherapy 16 (5.3) 
No Treatment 40 (13.3) 
Survival Status  
Alive 208 (69.1) 
Dead 93 (30.9) 
 
 
Table 3. Types of oral cancers of different histopathological origins. 
Histopathological Origin Site Distribution N (%) 
Epithelial Origin (N / %)   
Squamous Cell Carcinoma (211 / 70.1%) Tongue 98 (46.4) 
 Anterior Tongue 61 
 Posterior Tongue 37 
 Buccal Mucosa 33 (15.6) 
 Floor of Mouth 22 (10.4) 
 Sinus 17 (8.0) 
 Nasal Sinus 8 
 Maxillary Sinus 5 
 Paranasal Sinus 2 
 Sphenoidal Sinus 2 
 Alveolus 12 (5.7) 
 Upper Alveolus 3 
 Lower Alveolus 9 
 Gland 12 (5.7) 
 Parotid Gland 8 
 Submandibular Gland 4 
 Lip 10 (4.7) 
 Upper Lip 7 
 Lower Lip 3 
 Hard Palate 7 (3.3) 
Basal Cell Carcinoma (6 / 2.0) Lip 4 (66.7) 
 Lower Lip 4 
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 Gland 2 (33.3) 
 Parotid Gland 1 
 Submandibular Gland 1 
Basaloid Squamous Cell Carcinoma (4 / 1.3) Floor of Mouth 2 (50.0) 
 Tongue 1 (25.0) 
 Anterior Tongue 1 
 Gland 1 (25.0) 
 Parotid Gland 1 
Malignant Melanoma (3 /1.0) Palate 2 (75.0) 
 Hard Palate 2 
 Alveolus 1 (25.0) 
 Lower Alveolus 1 
Glandular Origin   
Mucoepidermoid Carcinoma (25 / 8.3) Gland 15 (60.0) 
 Parotid Gland 14 
 Submandibular Gland 1 
 Palate 6 (24.0) 
 Hard Palate 5 
 Soft Palate 1 
 Floor of Mouth 3 (12.0) 
 Alveolus 1 (4.0) 
 Upper Alveolus 1 
Adenoid Cystic Carcinoma (17 / 5.6) Gland 12 (70.6) 
 Submandibular Gland 7 
 Parotid Gland 5 
 Buccal Mucosa 3 (17.6) 
 Tongue 1 (5.9) 
 Anterior Tongue 1 
 Sinus 1 (5.9) 
 Sphenoidal Sinus 1 
Adenocarcinoma (7 / 2.3) Gland 5 (71.4) 
 Parotid Gland 3 
 Submandibular Gland 2 
 Lip 1 (14.3) 
 Lower Lip 1 
 Sinus 1 (14.3) 
 Nasal Sinus 1 
Acinic Cell Carcinoma (3 / 1.0) Gland 3 (100.0) 
 Parotid Gland 3 
Mesenchymal Origin   
Rhabdomyosarcoma (6 / 2.0) Buccal Mucosa 3 (50.0) 
 Alveolus 1 (16.7) 
 Lower Alveolus 1 
 Lip 1 (16.66%) 
 Lower Lip 1 
 Gland 1 (16.7) 
 Submandibular Gland 1 
Leiomyosarcoma (4 / 1.3) Tongue 2 (50.0) 
 Anterior Tongue 2 
 Lip 1 (25.0) 
 Lower Lip 1 
 Palate 1 (25.0) 
 Hard Palate 1 
Angiosarcoma (3 / 1.0) Tongue 2 (66.7) 
 Anterior Tongue 2 
 Gland 1 (33.3) 
 Parotid Gland 1 
B-cell lymphoma (3 / 1.0) Tongue 3 (100.0) 
 Anterior Tongue 2 
 Posterior Tongue 1 
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Osteosarcoma (3 / 1.0) Palate 3 (100.0) 
 Hard Palate 3 
Pleomorphic sarcoma (2 / 0.7) Palate 1 (50.0) 
 Hard Palate 1 
 Sinus 1 (50.0) 
 Nasal Sinus 1 
Mixed/Other Origins   
Lymphoepithelial Carcinoma (4 / 1.3) Gland 3 (75.0) 
 Parotid Gland 3 
 Lip 1 (25.0) 
 Upper Lip 1 
 
The tongue was the most commonly involved part of the oral cavity with OC (35.5%), followed by 
major salivary glands, including the parotid gland and submandibular gland (18.3%) and buccal mucosa 
(13.0%) (Table 4). 
 
Table 4. Data distribution based on site of oral cancer. 
Cancer Site N (%) 
Tongue 107 (35.5) 
Anterior 69 
Posterior 38 
Buccal Mucosa 39 (13.0) 
Floor of Mouth  27 (9.0) 
Gingiva  15 (5.0) 
Upper Gingiva  4 
Lower Gingiva 11 
Lips 18 (6.0) 
Upper Lip 8 
Lower Lip 10 
Glands  55 (18.3) 
Parotid Gland 39 
Submandibular Gland  16 
Palate 20 (6.6) 
Hard Palate 19 
Soft Palate 1 
Sinuses 20 (6.6) 
Nasal Sinus 10 
Paranasal Sinus 2 
Sphenoid Sinus 3 
Maxillary Sinus  5 
 
In the 19-year period (2000-2018), 86.7% patients had received treatment, while 13.3% did not receive 
any treatment. A total of 74.7% of patients who had undergone treatment lived, while 67.5% who did not 
receive any treatment died (Table 5). 
 
Table 5. Status of treatment outcome in oral cancer patients. 
 Treatment Outcome Status  
Treatment Alive  Dead  Total 
 (N / %) (N / %) (N / %) 
Yes 195 (74.7) 66 (25.3) 261 (86.7) 
No 13 (32.5) 27 (67.5) 40 (13.3) 
Total 208 (69.1) 93 (30.9) 301 (100.0) 
 
Discussion 
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Improvement of disease control is largely dependent on identifying risk factors and the epidemiology 
of that specific disease. Provisions of symptomatic treatment to cancer patients fail to help the cancer control 
strategies. The current study determined the types of OCs reported since the year 2000 in Hospital Universiti 
Sains Malaysia, located in Kelantan, Malaysia. This study also explored the association of OC with socio-
demographic and clinic-pathological risk factors. 
Globally, it has been well reported that the incidence of OC escalates with increasing age. Individuals 
above forty years of age are at peak risk for developing OC [12]. The mean age of 55 years was determined in 
the present study, which is in accordance with the data from Yemen, Pakistan, and a multi-center study 
[5,12,13]. The occurrence of OSCC was commonly observed in the sixth decade of life, which has been 
reported in several studies [13-17]. Several histopathological origins, including epithelial, glandular, and 
mesenchymal, were reported to commonly occur at different times [17]. According to gender, male cases were 
common than females, with a male ratio of 1.68 to 1. Our data's gender distribution was comparable with the 
Pakistani and African population [13,17]; however, the male predilection was observed up to 4.3:1 in multi-
center studies involving larger sample data [12,16]. These findings are in accordance with multiple studies 
conducted to associate the age [13-16] and gender factors [15,17-20] with the increasing risk of developing 
OC. 
We found that 70.1% of cases in this study had OSCC. Oral squamous cell carcinoma has been 
identified as the most commonly occurring malignant tumor of the oral cavity [1,13-15,17]. Several studies 
described their results by dividing the malignancies into different regions such as oropharynx, oral cavity, 
pharynx, and larynx [5,12,13]. The present study presented the data distribution based on the site of the 
tumor; and that within the oral cavity, the tongue was the most common tumor site, which is in accordance 
with several other studies [5,12,13] and in agreement with global epidemiology data that reported tongue as 
the most “cancer-prone” intra-oral site in most populations [21]. The site distribution was different in this 
study as compared with other studies conducted in other Asian countries, whereby the most frequent site of 
OSCC was buccal mucosa. This might be due to the habitual practice of placing betel quid between teeth and 
buccal mucosa, as commonly observed in populations of India, Myanmar, Thailand, and Taiwan [22]. In 
Malaysia and Indonesia, betel quid chewing habit has been primarily replaced with smoking since early to mid-
1990s [23]. The second most common tumor site within the oral cavity included parotid and submandibular 
glands, which was also found to be in opposition to several other studies [12,18-20]. 
The present study's findings are in accordance with the TNM classification recommended for 
classifying malignant tumors [22]. The highest number of subjects presented with the T2 stage closely 
followed by the T4 stage, whereas Mendez et al. [8] reported most cases with the T4 stage. 69% of the present 
study cases were alive at follow-up, which included the cases that did not undergo any form of treatment. The 
majority of patients presenting at the T4 stage were not surgically operated, explaining the high incidence of 
cases receiving no treatment. We identified that different studies described their results based on different 
classification systems, histopathology [15], nature of the tumor (benign or malignant) [14], site of the tumor 
[18], grading of differentiation [13] and involved region [5,12].  
In the present study, the majority of the patients received a combination of surgery and RT. This 
finding coincides with the guidelines of the National Comprehensive Cancer Network (NCCN). According to 
NCCN, the standard of care for early-stage resectable (T1/T2) OSCC is surgery and/or RT; the majority of 
surgeons give preference to primary resection with or without elective neck dissection [24]. For early-stage 
disease, equivalent loco-regional control rates can be obtained in comparison to surgery; however, RT requires 
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both external beam and brachytherapy to be used together [25]. There is no robust prospective study 
comparing the 2 modalities against one another, but a single case series demonstrated superior loco-regional 
control with definitive surgical resection compared to definitive RT for early-stage OC [26]. However, 
previous authors pointed out that these patients received less intense treatment protocols than those 
recommended today [27]. Huang et al. performed a retrospective study of 148 patients with T1/T2, N0 
disease, and documented clear margins after definitive surgical resection with >90% loco-regional control 
[28]. 
The RT by itself may be offered to patients with unresectable disease, the recurrent disease not 
amenable to further resection, patients who refuse surgery or are deemed too medically unstable for surgery 
(ie, significant comorbidities, poor functional status), as well as patients in whom RT is determined to avoid 
significant functional/cosmetic disability [27,29]. The advantage of surgical resection over RT may be 
several-fold; RT has sequelae that can significantly impact the quality of life, including xerostomia, dysphagia, 
and osteoradionecrosis [29]. Moreover, the treatment course can be close to 2 months, whereas surgical 
treatment of early OSCC has a quicker recovery [29]. In general, oral cavity cancers are best treated with 
surgery, whereas definitive RT should only be used if surgery is unable to be performed or is refused by the 
patient. 
The future recommendation includes that emphasis should be made to follow guidelines designed to 
standardize the screening and reporting of any observational study to perform comparative studies in different 
populations. The importance of the development of a consensus of the ontology of oral cancers is also stressed 
upon. This would ease the process of systematic searching of the available literature with the elimination of 
potential bias. A countrywide screening of potential cancer risk in different public and private tertiary care 
centers will facilitate in establishing cancer control and will play a pivotal role in spreading awareness of this 
disease. This report will serve as a database of the OC burden in Northeastern Peninsular Malaysia. 
 
Conclusion 
Despite the presence of a high incidence of metastasis and a high proportion of cases who did not 
receive any form of treatment, around three-fourth of the total oral cancer patients were alive at the time of 
this study. 
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